In Reply: Among the suggestions in my Commentary was to replace the vague label “translational research” with more descriptive terms that better differentiate T1 from T2, and I commend both letters for beginning to examine the options. The terms suggested by Dr Fiscella and colleagues—preclinical research and applied clinical research—are useful to consider but may be inadequate to clear up the confusion. Whether or not applied clinical research was meant to include conventional drug and device trials, those who conduct such studies are likely to assume that their work falls under this category. Conversely, public health and health services researchers might be confused to see the term applied to their work.
Woolf SH. Nomenclature in Translational Research—Reply. JAMA. 2008;299(18):2148-2150. doi:10.1001/jama.299.18.2149-b